Shuttle Pharmaceuticals is trading at $3.24 (-9.11%) in pre-market, pulling back after a significant gain in the previous session.
- The move follows a 9.51% surge on July 8, suggesting a correction or profit-taking by investors after a volatile trading day.
- No new company-specific earnings, regulatory filings, or major announcements were identified for July 9, 2026, to explain the downward movement.
- The broader market is trading only modestly higher in pre-market, indicating the decline is likely a technical retracement rather than a market-wide trend.